AspenBio president and CEO Steve Lundy said they have dedicated time and resources to advancing their quality management system and are very pleased with this achievement.

"These certifications validate our team’s commitment to deliver products and are a major milestone as we advance AppyScore towards commercial launch," Lundy said.

AppyScore is a blood-based test in development which aids physicians to manage appendicitis patients suffering from abdominal pain.